S.637: CURE High Drug Prices Act

About This Bill

Bill Version

Bill Summary

Combatting Unreasonable Rises and Excessively High Drug Prices Act or the CURE High Drug Prices Act This bill prohibits price gouging by manufacturers of prescription drugs (including a combination of a drug, device, or biological product) that are covered by a federal health care program. The bill specifies percentage increases in price at which price gouging is presumed.

(Source: Library of Congress)

Bill Actions

Date Description
Feb. 28, 2019
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Feb. 28, 2019

Introduced in the Senate by Richard Blumenthal (D-Conn.)

Close Comment Creative Commons Donate Email Facebook Mobile Phone Podcast Print Google News logo Google_NewsInitiative_Lockup_FullColor RSS Search Search Twitter WhatsApp Resolving differences Check Building Arrow right Info circle Oops OOPS Pencil File text Bars Search Close Cogs Filter Compare Revolving Door Info card Activity Member menu Globe Document External link Quote News Calendar No Vote
Current site Current page